ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 1 filers reported holding ADICET BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,941 | -45.6% | 10,906 | -3.6% | 0.00% | -100.0% |
| Q2 2023 | $27,488 | +161594.1% | 11,312 | +287.5% | 0.00% | 0.0% |
| Q1 2023 | $17 | +30.8% | 2,919 | +114.6% | 0.00% | 0.0% |
| Q4 2022 | $13 | -100.0% | 1,360 | -28.3% | 0.00% | – |
| Q3 2022 | $27,000 | +28.6% | 1,897 | +32.3% | 0.00% | – |
| Q2 2022 | $21,000 | -85.8% | 1,434 | -80.7% | 0.00% | -100.0% |
| Q1 2022 | $148,000 | +469.2% | 7,427 | +397.1% | 0.00% | – |
| Q4 2021 | $26,000 | +188.9% | 1,494 | +29.0% | 0.00% | – |
| Q3 2021 | $9,000 | -67.9% | 1,158 | -57.6% | 0.00% | -100.0% |
| Q2 2021 | $28,000 | -12.5% | 2,733 | +10.3% | 0.00% | 0.0% |
| Q1 2021 | $32,000 | +190.9% | 2,477 | +231.1% | 0.00% | – |
| Q4 2020 | $11,000 | -60.7% | 748 | -67.7% | 0.00% | – |
| Q3 2020 | $28,000 | – | 2,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |